289 research outputs found

    Comparative visualization across physical and parameter space

    Get PDF
    We designed and developed an interactive visualization approach for exploring and comparing image sequences in the context of porous media research. Our tool facilitates the visual analysis of two-dimensional image sequence datasets captured during fluid displacement experiments in a porous micromodel. The images are aggregated into a single graph-based representation, allowing for an experiment to be visualized across its entire temporal domain. This graph is generated from the viscous flow patterns of the invading fluid, reducing the need for manual image masking and clean-up steps. The Node-Link representation of the graph is superimposed onto the raw images, creating a composite spatio-temporal view of the dataset. We demonstrate the functionality of our implementation by evaluating its output and performance on a collection of related datasets. We found that separate experiments in the same porous medium yield topologically different, yet visually similar flow graphs with comparable node positions.Wir haben eine interaktive Visualisierungsmethode für die Exploration und den Vergleich von Bildsequenzen im Kontext der Erforschung poröser Medien entworfen und entwickelt. Unser Werkzeug unterstützt die visuelle Analyse zweidimensionaler Bildsequenzdaten, die aus Experimenten zur Flüssigkeitsverdrängung in porösen Mikromodellen gewonnen wurden. Die Bilder werden in eine einheitliche Graph-basierte Repräsentation aggregiert, die es ermöglicht, ein Experiment über seine gesamte Zeitspanne zu visualisieren. Dieser Graph wird aus den viskosen Strömungsmustern der eindringenden Flüssigkeit erzeugt, wodurch die Notwendigkeit manueller Bildmaskierungs- und Säuberungsschritte reduziert wird. Die Node-Link-Repräsentation dieses Graphen wird mit den Rohbildern überlagert, um eine zusammengesetzte räumliche und zeitliche Ansicht des Datensatzes zu erhalten. Wir demonstrieren die Funktionalität unserer Implementierung, indem wir ihre Ausgabe und ihr Laufzeitverhalten mittels einer Sammlung zusammenhängender Datensätze evaluieren. Wir stellten fest, dass separate Experimente im selben porösen Medium topologisch unterschiedliche, aber visuell ähnliche Flussgraphen mit vergleichbaren Knotenpositionen ergeben

    Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus

    Get PDF
    Background: Type 2 diabetes, a highly prevalent chronic disease, is associated with increasing frailty and functional decline in older people. We aimed to evaluate the effectiveness of a multimodal intervention on functional performance in frail and pre-frail participants aged >= 70 years with type 2 diabetes mellitus. Methods: The MID-Frail study was a cluster-randomized multicenter clinical trial conducted in 74 trial sites across seven European countries. The trial recruited 964 participants who were aged >70 years [mean age in intervention group, 78.4 (SD 5.6) years, 49.2% male and 77.6 (SD 5.29) years, 52.4% male in usual care group], with type diabetes mellitus and determined to be frail or pre-frail using Fried's frailty phenotype. Participants were allocated by trial site to follow either usual care (UCG) or intervention procedures (IG). Intervention group participants received a multimodal intervention composed of (i) an individualized and progressive resistance exercise programme for 16 weeks; (ii) a structured diabetes and nutritional educational programme over seven sessions; and (iii) Investigator-linked training to ensure optimal diabetes care. Short Physical Performance Battery (SPPB) scores were used to assess change in functional performance at 12 months between the groups. An analysis of the cost-effectiveness of the intervention was undertaken using the incremental cost-effectiveness ratio (ICER). Secondary outcomes included mortality, hospitalization, institutionalization, quality of life, burden on caregivers, the frequency and severity of hypoglycaemia episodes, and the cost-effectiveness of the intervention. Results: After 12 months, IG participants had mean SPPB scores 0.85 points higher than those in the UCG (95% CI, 0.44 to 1.26, P < 0.0001). Dropouts were higher in frail participants and in the intervention group, but significant differences in SPPB between treatment groups remained consistent after sensitivity analysis. Estimates suggest a mean saving following intervention of 428.02 EUR (2016) per patient per year, with ICER analysis indicating a consistent benefit of the described health care intervention over usual care. No statistically significant differences between groups were detected in any of the other secondary outcomes. Conclusions: We have demonstrated that a 12 month structured multimodal intervention programme across several clinical settings in different European countries leads to a clinically relevant and cost-effective improvement in the functional status of older frail and pre-frail participants with type 2 diabetes mellitus

    Essential steps in primary care management of older people with Type 2 diabetes: an executive summary on behalf of the European geriatric medicine society (EuGMS) and the European diabetes working party for older people (EDWPOP) collaboration

    Get PDF
    Abstract We present an executive summary of a guideline for management of type 2 diabetes mellitus in primary care written by the European Geriatric Medicine Society, the European Diabetes Working Party for Older People with contributions from primary care practitioners and participation of a patient’s advocate. This consensus document relies where possible on evidence-based recommendations and expert opinions in the fields where evidences are lacking. The full text includes 4 parts: a general strategy based on comprehensive assessment to enhance quality and individualised care plan, treatments decision guidance, management of complications, and care in case of special conditions. Screening for frailty and cognitive impairment is recommended as well as a comprehensive assessment all health conditions are concerned, including end of life situations. The full text is available online at the following address: essential_steps_inprimary_care_in_older_people_with_diabetes_-_EuGMS-EDWPOP___3_.pdf.Abstract We present an executive summary of a guideline for management of type 2 diabetes mellitus in primary care written by the European Geriatric Medicine Society, the European Diabetes Working Party for Older People with contributions from primary care practitioners and participation of a patient’s advocate. This consensus document relies where possible on evidence-based recommendations and expert opinions in the fields where evidences are lacking. The full text includes 4 parts: a general strategy based on comprehensive assessment to enhance quality and individualised care plan, treatments decision guidance, management of complications, and care in case of special conditions. Screening for frailty and cognitive impairment is recommended as well as a comprehensive assessment all health conditions are concerned, including end of life situations. The full text is available online at the following address: essential_steps_inprimary_care_in_older_people_with_diabetes_-_EuGMS-EDWPOP___3_.pdf

    Essential steps in primary care management of older people with Type 2 diabetes: an executive summary on behalf of the European geriatric medicine society (EuGMS) and the European diabetes working party for older people (EDWPOP) collaboration

    Get PDF
    We present an executive summary of a guideline for management of type 2 diabetes mellitus in primary care written by the European Geriatric Medicine Society, the European Diabetes Working Party for Older People with contributions from primary care practitioners and participation of a patient’s advocate. This consensus document relies where possible on evidence-based recommendations and expert opinions in the fields where evidences are lacking. The full text includes 4 parts: a general strategy based on comprehensive assessment to enhance quality and individualised care plan, treatments decision guidance, management of complications, and care in case of special conditions. Screening for frailty and cognitive impairment is recommended as well as a comprehensive assessment all health conditions are concerned, including end of life situations. The full text is available online at the following address: essential_steps_inprimary_care_in_older_people_with_diabetes_-_EuGMS-EDWPOP___3_.pdf

    An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes--the MID-Frail study: study protocol for a randomised controlled trial

    Get PDF
    Incluye 2 ficheros de datosBackground: Diabetes, a highly prevalent, chronic disease, is associated with increasing frailty and functional decline in older people, with concomitant personal, social, and public health implications. We describe the rationale and methods of the multi-modal intervention in diabetes in frailty (MID-Frail) study. Methods/Design: The MID-Frail study is an open, randomised, multicentre study, with random allocation by clusters (each trial site) to a usual care group or an intervention group. A total of 1,718 subjects will be randomised with each site enrolling on average 14 or 15 subjects. The primary objective of the study is to evaluate, in comparison with usual clinical practice, the effectiveness of a multi-modal intervention (specific clinical targets, education, diet, and resistance training exercise) in frail and pre-frail subjects aged ≥70 years with type 2 diabetes in terms of the difference in function 2 years post-randomisation. Difference in function will be measured by changes in a summary ordinal score on the short physical performance battery (SPPB) of at least one point. Secondary outcomes include daily activities, economic evaluation, and quality of life. Discussion: The MID-Frail study will provide evidence on the clinical, functional, social, and economic impact of a multi-modal approach in frail and pre-frail older people with type 2 diabetes. Trial registration: ClinicalTrials.gov: NCT01654341.This study was funded by the European Commission Seventh Framework Programme

    Der Patient mit Parkinson

    Full text link

    Lungen- und Atemwegserkrankungen

    Full text link
    corecore